As Omicron-specific boosters are in the news, BioNTech to expand German site workforce by 200 employees

As Omicron-specific boosters are in the news, BioNTech to expand German site workforce by 200 employees

Source: 
Endpoints
snippet: 

Testing for the vaccine tailored to the pesky variant — which has been deemed more transmissible with less severe symptoms for those that are vaccinated — began this week, BioNTech said along with Pfizer. The trial will test 1,420 healthy adults under the age of 55. Three groups of people, representing different levels of immunity,

In March 2021, Marburg began producing Covid-19 vaccines. It started with the production of mRNA, the active pharmaceutical ingredient for the vaccine. The first batch of doses shipped out in April.